Cargando…
Thrombosis post-mRNA-based SARS-CoV-2 vaccination (BNT162b2) – Time to think beyond thrombosis with thrombocytopenia syndrome (TTS)
The COVID-19 pandemic has affected the global socioeconomic and healthcare infrastructure. Vaccines have been the cornerstone in limiting the global spread of the pandemic. However, the mass scale vaccination has resulted in some unanticipated adverse events. Arguably the most serious of these has b...
Autores principales: | Yousaf, Zohaib, Ata, Fateen, Mohammed Hammamy, Riyadh Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9013693/ http://dx.doi.org/10.1016/j.tru.2022.100104 |
Ejemplares similares
-
Development and Validation of an Algorithm for Thrombosis with Thrombocytopenia Syndrome (TTS) at Unusual Sites
por: Hobbi, Shayan, et al.
Publicado: (2023) -
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman
por: Alhashim, Ali, et al.
Publicado: (2022) -
Coronary thrombosis in a young male with COVID-19
por: Shams, Abdullah, et al.
Publicado: (2020) -
Use of SGLT‐2 inhibitor in COVID‐19: A cautionary tale
por: Yousaf, Zohaib, et al.
Publicado: (2021) -
Cerebral venous sinus thrombosis as the initial presentation of essential thrombocythemia - A case report and literature review
por: Yousaf, Qudsum, et al.
Publicado: (2022)